Update shared on17 Sep 2025
Fair value Increased 2.21%The modest increase in Chemours’ Consensus Analyst Price Target reflects slightly higher forward P/E expectations, while the discount rate remains stable, resulting in a revised fair value of $15.44.
What's in the News
- Chemours signed strategic agreements with SRF Limited to enhance global supply chain, increase operational flexibility, and access capacity for fluoropolymers and fluoroelastomers, with no upfront capital investment required.
- Samsung Electronics successfully qualified Chemours' Opteon™ two-phase immersion cooling fluid for use with its generation four SSDs, supporting further adoption of Chemours' cooling technology in data centers.
- Chemours provided third-quarter guidance for a 4-6% sequential decline in net sales; full-year 2025 net sales expected at $5.9–6.0 billion with a net loss of $336–300 million.
- Chemours, DuPont, and Corteva reached a proposed $875 million settlement with New Jersey to resolve pending PFAS-related claims, with Chemours responsible for 50% of payments, and structured insurance arrangements to fund obligations through at least 2030.
- Chemours was reclassified from various Russell indexes, being dropped from several value and midcap benchmarks while added to the Russell 2000 and Russell 2000 Growth indexes.
Valuation Changes
Summary of Valuation Changes for Chemours
- The Consensus Analyst Price Target has risen slightly from $15.11 to $15.44.
- The Future P/E for Chemours has risen slightly from 4.61x to 4.72x.
- The Discount Rate for Chemours remained effectively unchanged, moving only marginally from 10.95% to 10.83%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.